Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jasa Armada Indonesia Tbk. (IPCM) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Jasa Armada Indonesia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Jasa Armada Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Jasa Armada Indonesia Tbk. trades at Rp300 (market cap 1.61T, 1.9M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 177.6K 24h volume). The key difference: Jasa Armada Indonesia Tbk. is far larger — about 9.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Jasa Armada Indonesia Tbk. is more actively traded (1.9M versus 177.6K). Which is the better fit depends on your goals.

IPCMOBAT
Market Cap
1.61T164.65B
Volume
1.9M177.6K
Lot
19.02K1.78K
Turnover
558.3M42M
Average Price
293.61236.47
Value
558.3M42M
Indicative Equilibrium Price
304242
Indicative Equilibrium Volume
4K500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IPCM
View details
OBAT
View details

About Jasa Armada Indonesia Tbk.

PT Jasa Armada Indonesia (“the Company") was established based on Notarial Deed No. 24 dated July 10, 2013 of Nur Muhammad Dipo Nusantara Pua Upa, S.H., M.Kn., notary in Jakarta. The Company’s parent is PT Pelabuhan Indonesia II (Persero) and the Company’s ultimate parent is the Government of the Republic of Indonesia.

Read more on IPCM

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT